Aurobindo Pharma Limited Price, Chart & Factor Exposure
Free Data & Analytics AccessNext earnings: Tue, Feb 9, 2027, before the market opens · estimates and history
Aurobindo Pharma Limited Forecast
Aurobindo Pharma Limited short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 26.5% a year, a typical one-standard-deviation range is 1,621–1,747 over a week, 1,555–1,813 over a month and 1,237–2,130 over a year. (Signals as of 5 Nov 2026.)
Aurobindo Pharma Limited Price Chart
Aurobindo Pharma Limited Factors
YoY +18.7%
YoY +22.0%
YoY +23.0%
YoY +18.4%
YoY +22.2%
YoY −15.7%
YoY +38.3%
YoY +22.8%
YoY +4.9%
YoY −6.6%
YoY −5.9%
YoY +27.0%
YoY −1.5%
YoY 0.0%
Aurobindo Pharma Limited fundamentals: income statement, balance sheet & cash flow
Aurobindo Pharma Limited reported revenue of 336.53bn INR and net income of 35.05bn INR in FY2026, the year ended 31 March 2026 — revenue up 6.1% and net income up 0.5% on the prior year. Free cash flow was 28.27bn INR. These figures are as reported in the filings, not restated: 23 fiscal years and 60 quarters of history, back to March 2004.
| INR billions | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Revenue | 336.53 | 317.24 | 290.02 | 248.55 | 234.55 |
| Cost of revenue | 204.57 | 134.84 | 129.86 | 116.42 | 104.50 |
| Gross profit | 131.96 | 182.40 | 160.16 | 132.14 | 130.06 |
| Research & development | 1.55 | 16.92 | 15.22 | 14.53 | 16.25 |
| Selling, general & admin. | 79.63 | — | 40.43 | 36.56 | 35.75 |
| Operating income | 50.78 | 120.01 | 104.50 | 81.05 | 78.06 |
| EBITDA | 72.74 | 65.78 | 58.83 | 37.56 | 44.33 |
| Interest expense | 3.84 | 4.57 | 2.90 | 1.40 | 0.49 |
| Pre-tax income | 51.12 | 50.66 | 43.80 | 26.13 | 33.73 |
| Income tax | 16.09 | 15.83 | 12.11 | 6.85 | 7.26 |
| Net income | 35.05 | 34.86 | 31.73 | 19.28 | 26.48 |
Download Aurobindo Pharma Limited fundamentals
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.AUROPHARMA.NSE&statement=all&freq=a&format=csv&years=10
Figures in INR, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.
Research on Aurobindo Pharma Limited
Explore MacroFinance macro & markets research and analysis.
Aurobindo Pharma Limited Trading Strategies
28 backtested tactical asset allocation strategies hold EEM (emerging markets), the closest tradable exposure to Aurobindo Pharma Limited; 2 of them are invested now. Strategies currently invested are listed first.
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
Statistical Distribution of Returns
PlusHow Aurobindo Pharma Limited’s returns are distributed — and how they change in a given market regime.
Regime filters
| Market/Macro | Indicator | Criteria | Value | And (for Between) | Action |
|---|
No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.
| Statistic | All periods | Matching |
|---|
About Aurobindo Pharma Limited (India)
Aurobindo Pharma Limited is a listed security in India. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
Frequently asked questions
What is Aurobindo Pharma Limited?
What is the latest Aurobindo Pharma Limited price?
Is Aurobindo Pharma Limited in an uptrend?
How volatile is Aurobindo Pharma Limited?
What factors affect Aurobindo Pharma Limited?
Which trading strategies trade Aurobindo Pharma Limited?
How are Aurobindo Pharma Limited returns analysed?
Where can I download free Aurobindo Pharma Limited historical data?
Free Aurobindo Pharma Limited historical data (last 10 years)
Browse or instantly download the last 10 years of Aurobindo Pharma Limited daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.AUROPHARMA.NSE&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-20 | 1799 |
| 2026-11-19 | 1805.7 |
| 2026-11-18 | 1796.3 |
| 2026-11-17 | 1794.1 |
| 2026-11-16 | 1794 |
| 2026-11-13 | 1823.2 |
| 2026-11-12 | 1807.2 |
| 2026-11-11 | 1827.5 |
| 2026-11-09 | 1848.3 |
| 2026-11-08 | 1797.19 |
About this stock
Aurobindo Pharma Limited, a pharmaceutical company, develops, manufactures, and commercializes generic pharmaceuticals in India, the United States, Europe, and internationally. The company manufactures a range of finished formulation products in various forms, such as oral solids, liquids, injectables for generic pharmaceuticals, branded specialty pharmaceuticals, and active pharmaceutical ingredients for CNS, anti-retroviral, cardiovascular, antibiotics, gastroenterology, anti-diabetics, and anti-allergic therapeutic areas. It also provides ointments, creams, gels, powders, transdermal, and lotions; antiretroviral drugs for PLHIV & CLHIV; and injectable products, including Penems, Penicillin, Cephalosporin, ophthalmic, inhalation, oncology, and hormone products. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.